CarisbaMate-d4(1292841-50-9)
- Name: CarisbaMate-d4
- Synonyms:CarisbaMate-d4
- Molecular Formula:
- Molecular Weight:0
- CAS Registry Number:1292841-50-9
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.1292841-50-9 Carisbamate-d4 CAS NO.1292841-50-9
Assay:99% Appearance:powder or liquid Package:according to customer requirements Storage:store in dry dark and ventilated place Transportation:By Sea/Air/Courier Application:It is an important raw material.
Min. Order:10Gram
Supplier:Zibo Hangyu Biotechnology Development Co., Ltd [
China (Mainland)]
CAS No.1292841-50-9 Carisbamate-d4
Assay:99.0% Appearance:liquid Package:Grams, Kilograms Storage:Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials. Transportation:According to customer request Application:For R&D and commerical use
Min. Order:100Gram
Supplier:Chemlyte Solutions [
China (Mainland)]
CAS No.1292841-50-9 (R)-Carisbamate beta-D-O-Glucuronide
Assay:95%+ or 98%+ Application:for drug impurity for drug standards,for drug research and development銆侱rug impurity reference, drug standard, analytical chemistry, standard substance, organic chemical synthesis, chemical custo...
Min. Order:25Milligram
Supplier:Hubei Moxin Biotechnology Co., Ltd [
China (Mainland)]
CAS No.1292841-50-9 CarisbaMate-d4
Assay:99% Appearance:liquid or powder Package:according to the clients requirement Storage:Dry and Cool Place Transportation:UPS FedEx ,DHL,EXPRESS LINE Application:API
Min. Order:1Gram
Supplier:Shandong Mopai Biotechnology Co., LTD [
China (Mainland)]
CAS No.1292841-50-9 Carisbamate-d4
Assay:95% Package:inquiry Transportation:inquiry Application:labelled Carisbamate; it is being developed for adjuvant treatment of partial onset epilepsy. Carisbamate produces anticonvulsant effects in primary generalized, complex partial and absence-type seizu
Min. Order:1Gram
Supplier:BOC Sciences [
United States]

Other Product
- 3625-02-3/2-Phenanthrenol, 4b,5,6,7,8,8a-hexahydro-4b,8,8-trimethyl-1-(1-methylethyl)-, (4bS,8aS)-
- 915924-34-4/1-[(5-METHYL-1,2,4-OXADIAZOL-3-YL)METHYL]PIPERAZINE
- 261762-53-2/3-CHLORO-2,6-DIFLUOROPHENYLACETIC ACID
- 517902-22-6/N-(6-amino-1,3-benzothiazol-2-yl)-2-furamide
- 80944-63-4/5-Nitro-2-pyridyl Diphenylphosphinate
- 1527517-47-0/4-amino-N-(1H-indol-5-yl)thieno[3,2-d]pyrimidine-7-carboxamide
- 1196155-54-0/cyclopropaneethanesulfonyl chloride
- 1187932-75-7/3(S)-CHLOROMETHYL-PYRROLIDINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER
- 1261470-87-4/4-Bromo-2-iodobenzaldehyde
- 1154760-03-8/2-(N-tert-butoxycarbonyl-3-hydroxyazetidin-3-yl)acetic acid
- 769917-29-5/6-[4-(1H-IMIDAZOL-1-YL)-PHENOXY]-N,N-DIMETHYL-1-HEXANAMINE
- 1352072-62-8/2-cyclopropyl-1-(pyridin-2-yl)ethanol
- 324014-39-3/SALOR-INT L483575-1EA
- 608537-88-8/2-Furanmethanamine,alpha-methyl-4-(1-methylethyl)-,(alphaR)-(9CI)
- 78629-17-1/2-(1-NAPHTHYL)PIPERIDINE
- 16999-21-6/SCANDIUM NITRATE
- 383425-11-4/N,N-Dimethyl-2-piperidinecarboxamide hydrochloride
- 1048389-45-2/2,4-dichloro-6-(methylsulfonyl)Pyrimidine
- 134236-23-0/1,2-Propanediol diacetate
- 1292841-50-9/CarisbaMate-d4
- 361380-77-0/3,5-DIMETHYL-1H-PYRROLE-2,4-DICARBOXYLIC ACID 4-TERT-BUTYL ESTER 2-ETHYL ESTER
- 205527-20-4/1-(4-CHLORO-PHENYL)-2-[2-(4-CHLORO-PHENYL)-2-HYDROXY-ETHYLSULFANYL]-ETHANOL
- 84087-33-2/QUINCLORAC-METHYL ESTER
- 189144-54-5/Phenyl 3-O-(phenylmethyl)-1-thio-beta-D-glucopyranoside
- 885519-60-8/4,6-DICHLORO-3-IODO-1H-INDAZOLE
- 1394827-71-4/(3R,4S)-1-Benzyl-4-(3-chlorophenyl)pyrrolidine-3-carboxylic acid
- 2160-11-4/2,3-Diamino-1,4-dichloro-5-methylbenzene
- 874834-12-5/Ethyl 1-(benzo[c][1,2,5]thiadiazol-5-ylMethyl)piperidine-4-carboxylate
- 947583-96-2/4-bromo-2-(trifluoromethoxy)benzenemethan amine
- 1420981-17-4/benzyl (2-(diMethylaMino)cyclohexyl)carbaMate